Literature DB >> 6096489

Sequence of the putative origin of replication in the UL region of herpes simplex virus type 1 ANG DNA.

C P Gray, H C Kaerner.   

Abstract

Interest has been stimulated concerning the region mapping between 0.38 and 0.42 on the prototype configuration of the herpes simplex virus type 1 (HSV-1) genome due to the high probability of the presence there of a second origin of DNA replication. A 960 bp restriction fragment (HinfI E) of a class II defective HSV-1 ANG DNA has been sequenced using the viral DNA rather than molecularly cloned DNA. This fragment includes the BamHI U/R cleavage site, mapping at approximately 0.4. Part of the sequence derived in this study displays homology with the origins of DNA replication contained in TRS/IRS of HSV-1 and HSV-2 DNA. The homologous region comprising 76 bp occurs as two copies, each of which contains two palindromically arranged copies of an 8 bp sequence identical to the 'consensus' sequence reported to be part of the origin of DNA replication at the terminus of the mammalian adenoviruses. It can be deduced from a comparison of this structure to the TRS/IRS origin of HSV-1 and HSV-2 that there are two origins of replication in the UL region of HSV-1 ANG DNA. Assuming that the orientation of the consensus sequence is relevant to the direction of DNA replication, one can conclude that the UL origin(s) of HSV-1 ANG is (are) bidirectional. It has not yet been possible to clone DNA fragments molecularly which include the region spanning the UL origin(s) of HSV-1 DNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096489     DOI: 10.1099/0022-1317-65-12-2109

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Herpes simplex virus type 1 oriL is not required for virus replication or for the establishment and reactivation of latent infection in mice.

Authors:  M Polvino-Bodnar; P K Orberg; P A Schaffer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Mutations in a herpes simplex virus type 1 origin that inhibit interaction with origin-binding protein also inhibit DNA replication.

Authors:  T R Hernandez; R E Dutch; I R Lehman; C Gustafsson; P Elias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Herpes simplex virus origin-binding protein (UL9) loops and distorts the viral replication origin.

Authors:  A Koff; J F Schwedes; P Tegtmeyer
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination.

Authors:  F M Hamzeh; P S Lietman; W Gibson; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Sequence and structural requirements of a herpes simplex viral DNA replication origin.

Authors:  D Lockshon; D A Galloway
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  A DNA helicase induced by herpes simplex virus type 1.

Authors:  J J Crute; E S Mocarski; I R Lehman
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

7.  A model for the development of the tandem repeat units in the EBV ori-P region and a discussion of their possible function.

Authors:  S Karlin; B E Blaisdell
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

8.  A DNA binding protein specific for an origin of replication of herpes simplex virus type 1.

Authors:  P Elias; M E O'Donnell; E S Mocarski; I R Lehman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Significant potential secondary structures in the Epstein-Barr virus genome.

Authors:  S Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: complementation of deletion mutants and inhibition of wild-type virus.

Authors:  P K Orberg; P A Schaffer
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.